Abstract
Background Clinical outcomes vary considerably among patients with acute single subcortical infarction (SSI). We aimed to construct a model incorporating radiomic features and clinical factors to predict functional outcomes in patients with acute SSI.
Methods We enrolled patients who experienced acute SSI within 14 days of stroke onset and randomly divided them into training (n=118) and test (n=30) cohorts. Unfavorable functional outcome was defined as a modified Rankin Scale score >1 at 3 months. We extracted and selected radiomics features from baseline diffusion-weighted imaging and perfusion-weighted imaging to develop a radiomics model. Multivariate logistic regression was performed to construct a clinical model using clinical factors and imaging features. Finally, a combined model was built using both clinical and radiomics features. Receiver operating characteristic curves were used to evaluate the discriminatory ability of these models.
Results The radiomics model, encompassing 13 radiomics features, exhibited good predictive performance for unfavorable functional outcomes with area under the curve (AUC) values of 0.774 and 0.824 in the training and test cohorts, respectively. The combined model, which included clinical factors (early neurological deterioration, hypertension, baseline National Institutes of Health Stroke Scale score, infarct volume, and summary cerebral small vessel disease score) and radiomics features, improved performance in the training (AUC = 0.915) and test (AUC = 0.846) cohorts.
Conclusions The clinical-radiomics model provided improved accuracy for the prognostic prediction of SSI, which may help clinicians in the decision-making process and improve long-term outcomes in patients with SSI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the National Key R&D Program of China (2023YFC2506603), the National Natural Science Foundation of China (82071320, 82271328, 82301661, and 82371322), the China Postdoctoral Science Foundation (2022M712249), the Post-Doctor Research Project, West China Hospital, Sichuan University (2023HXBH007), and the 1.3.5 project for disciplines of excellence, Clinical Research Incubation Project, West China Hospital, Sichuan University (2020HXFH012).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Biomedical Research Ethics Committee of West China Hospital (No. 2020 [324]).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
